WCM Investment Management LLC Sells 10,027 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

WCM Investment Management LLC lessened its position in Surgery Partners, Inc. (NASDAQ:SGRY) by 1.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 512,057 shares of the company’s stock after selling 10,027 shares during the quarter. WCM Investment Management LLC owned 0.40% of Surgery Partners worth $10,533,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the company. Principal Financial Group Inc. bought a new stake in Surgery Partners in the third quarter worth about $1,469,000. King Street Capital Management L.P. purchased a new stake in shares of Surgery Partners in the third quarter worth approximately $46,748,000. Royce & Associates LP lifted its stake in shares of Surgery Partners by 12.2% during the 3rd quarter. Royce & Associates LP now owns 510,261 shares of the company’s stock worth $16,451,000 after acquiring an additional 55,545 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Surgery Partners by 2.4% during the 3rd quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company’s stock valued at $60,117,000 after acquiring an additional 42,897 shares during the period. Finally, Victory Capital Management Inc. grew its position in Surgery Partners by 140.4% in the 3rd quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock valued at $42,892,000 after acquiring an additional 777,038 shares during the last quarter.

Surgery Partners Stock Up 0.6 %

Surgery Partners stock opened at $25.80 on Monday. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. The firm has a market cap of $3.28 billion, a P/E ratio of -53.75, a P/E/G ratio of 17.77 and a beta of 2.60. The business has a fifty day moving average of $21.84 and a two-hundred day moving average of $26.93. Surgery Partners, Inc. has a twelve month low of $19.50 and a twelve month high of $35.29.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The company had revenue of $770.40 million during the quarter, compared to the consensus estimate of $768.99 million. During the same period in the previous year, the firm posted $0.15 earnings per share. The company’s revenue was up 14.3% on a year-over-year basis. On average, analysts forecast that Surgery Partners, Inc. will post 0.71 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

SGRY has been the subject of several research analyst reports. UBS Group initiated coverage on Surgery Partners in a research report on Monday, October 14th. They set a “buy” rating and a $38.00 target price for the company. Macquarie reiterated an “outperform” rating and set a $34.00 price objective on shares of Surgery Partners in a report on Tuesday, November 19th. JPMorgan Chase & Co. dropped their target price on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research note on Tuesday, December 3rd. Bank of America started coverage on shares of Surgery Partners in a research report on Monday, December 16th. They set a “buy” rating and a $30.00 target price on the stock. Finally, Royal Bank of Canada lowered their price target on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a report on Wednesday, November 20th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $36.56.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.